Egle Therapeutics
Halina Novak is a Principal at FundPlus. Before that, they held various roles at different organizations such as Egle Therapeutics, Cardior Pharmaceuticals, EyeD Pharma, and TargED Biopharmaceuticals. Their experience includes leading collaborative projects, managing technology investment budgets, and developing flagship programs in the life sciences industry. Halina also has a background in scientific analysis, project management, and postdoctoral research. They hold degrees in Biological and Medicinal Chemistry, Biochemistry, and have also pursued education in Growth Through Innovation and Negotiating To Create Value.
This person is not in the org chart
This person is not in any offices
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.